Compositions and methods for protein electrophoresis
US-2025123240-A1 · Apr 17, 2025 · US
This page is not indexed by search engines while we improve data quality.
1,4-Oxazines; Hydrogenated 1,4-oxazines
1,4-Oxazines; Hydrogenated 1,4-oxazines · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D265/28 |
| Official title | 1,4-Oxazines; Hydrogenated 1,4-oxazines |
| Display label | 1,4-Oxazines; Hydrogenated 1,4-oxazines |
| Total patents | 22 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions and methods for protein electrophoresis
US-12163918-B1 · Dec 10, 2024 · US
N-substituted c6 cyclyl carboxamide compounds and uses thereof
US-2024360075-A1 · Oct 31, 2024 · US
Heterocyclic compounds
US-11814375-B2 · Nov 14, 2023 · US
Aryl ethene derivative and pharmaceutical composition containing same as active ingredient
US-11285226-B2 · Mar 29, 2022 · US
Antisense-induced exon exclusion in myostatin
US-2022090084-A1 · Mar 24, 2022 · US
Antisense-induced exon exclusion in myostatin
US-11015200-B2 · May 25, 2021 · US
Heterocyclic compounds
US-2021094943-A1 · Apr 1, 2021 · US
Production method for lithium sulfamate, and novel lithium sulfamate
US-2021087059-A1 · Mar 25, 2021 · US
Aryl ethene derivative and pharmaceutical composition containing same as active ingredient
US-10934303-B2 · Mar 2, 2021 · US
Electrochromic compound, electrochromic composition, and electrochromic display element
US-10935862-B2 · Mar 2, 2021 · US
Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
US-10836743-B2 · Nov 17, 2020 · US
Pyrrolopyrimidine compounds used as TLR7 agonist
US-10555949-B2 · Feb 11, 2020 · US
Electrochromic compound, electrochromic composition, and electrochromic display element
US-10534236-B2 · Jan 14, 2020 · US
New process for early sacubitril intermediates
US-2019256454-A1 · Aug 22, 2019 · US
Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
US-2019100507-A1 · Apr 4, 2019 · US
Antisense-induced exon exclusion in myostatin
US-2018355358-A1 · Dec 13, 2018 · US
Pyrrolopyrimidine compounds used as tlr7 agonist
US-2018303832-A1 · Oct 25, 2018 · US
Pyrrolopyrimidine compounds used as TLR7 agonist
US-9962388-B2 · May 8, 2018 · US
Partially fluorinated ketones and methods of making and using the same
US-9796691-B2 · Oct 24, 2017 · US